Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 3:04 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
View Ticker Page (GTXI)
Results 1 - 10 of 15 : 12
Recs
nilknarb194572 (< 20) Submitted: 2/21/07 12:42 PM : Start Price: $20.50 GTXI Score: 15.08
This drug is presently being tested for the treatment of prostrate cancer.Eight months ago it was tested on my friend along with a sugar pill the cancer is gone.I'm sure this drug is going to be around for a while.
Report this Post Replies: 1 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
aasp (< 20) Submitted: 1/05/07 10:25 PM : Start Price: $16.36 GTXI Score: 31.84
Program for mitigation of prostate problems (including cancer) appears to be on track and shows great promise. This stock has no middle ground. It will be a ten bagger or out of business in 5 yrs.
Report this Post Replies: 0 | Reply | Permalink
DANSEVILLE (< 20) Submitted: 4/10/08 9:33 PM : Start Price: $15.50 GTXI Score: 34.31
THERE ARE SEVERAL OPTIONS ON THE TABLE NOW. THERE WILL BE AN ANNOUCEMENT APRIL 12-15 CONCERNING THE FINAL TRAILS OF THEIR DRUGS
ResearchLover (< 20) Submitted: 3/25/08 7:49 PM : Start Price: $15.25 GTXI Score: 35.74
Speculative bet. I am a grad student and the concept of targeting nuclear receptors like estrogen receptor with compounds called SERMs (selective estrogen receptor modulators) is well established; I would predict if toxicology data are good (have to...
marinalee (45.05) Submitted: 8/22/07 5:32 AM : Start Price: $18.49 GTXI Score: 23.26
ready for the gate
johnearl12 (< 20) Submitted: 5/04/08 9:09 PM : Start Price: $18.21 GTXI Score: 22.44
It has a couple of Phase lll trials going on. It is about ready to pop. Great short term possibilities and great long term too. It has good buzz in the market place. Several reports state it will have unbelievable growth when the products hit the mar...
Tankota (99.83) Submitted: 5/15/08 1:03 PM : Start Price: $16.19 GTXI Score: -33.29
off target.
crl2007 (53.05) Submitted: 5/29/08 10:29 AM : Start Price: $15.40 GTXI Score: 37.20
s+p strong buy, reuters rated out-perform, target price $27
biovestor (< 20) Submitted: 6/28/08 6:29 AM : Start Price: $14.63 GTXI Score: 36.70
Promisng treatment for prostate cancer in late-stage development likely to fuel gains for GTXI over the next year or so.
LesMiles (67.26) Submitted: 5/30/06 10:13 PM : Start Price: $8.57 GTXI Score: 109.99
2 drugs (same drug @ different doses for different effects) in phase iii trials and 1 drug just starting phase ii trial with another candidate waiting in the wings.
Terms & Conditions
RSS Headlines
Fool UK